Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation

The BAATAF Investigators

Research output: Contribution to journalArticle

54 Scopus citations

Abstract

Background and Purpose: The Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF) demonstrated that low-intensity warfarin anticoagulation can, with safety, sharply reduce the rate of stroke in patients with nonvalvular atrial fibrillation. The beneficial effect of warfarin was presumably related to a decrease in clot formation in the cardiac atria and subsequent embolization. Methods: To assess the effect of warfarin therapy on in vivo clotting in patients in the BAATAF, we measured the plasma level of prothrombin activation fragment F1+2. One sample was obtained from 125 patients from the BAATAF; 62 were taking warfarin and 63 were not taking warfarin (control group). Results: The warfarin group had a 71% lower mean F1+2 level than the control group (mean F1+2 of 1.57 nmol/L in the control group compared with a mean of 0.46 nmol/L in the warfarin group; P<.001). F1+2 levels were higher in older subjects but were consistently lower in the warfarin group at all ages. Fifty-two percent of patients in the control group were taking chronic aspirin therapy at the time their F1+2 level was measured. Control patients taking aspirin had 1+2 levels very similar to control patients not taking aspirin (mean of 1.52 nmol/L for control patients on aspirin compared with 1.64 nmol/L for control patients off aspirin; P>.1). Conclusions: We conclude that prothrombin activation was significantly suppressed in vivo by warfarin but not aspirin among patients in the BAATAF. These findings correlate with the marked reduction in ischemic stroke noted among patients in the warfarin treatment group observed in the BAATAF.

Original languageEnglish (US)
Pages (from-to)1360-1365
Number of pages6
JournalStroke
Volume24
Issue number9
DOIs
StatePublished - Sep 1993

Keywords

  • Anticoagulants
  • Atrial fibrillation
  • Clinical trials
  • Warfarin

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Fingerprint Dive into the research topics of 'Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation'. Together they form a unique fingerprint.

  • Cite this